FDA Inspection 1205682 — Prof. Johnny Mahlangu
The FDA completed an inspection of Prof. Johnny Mahlangu on March 17, 2023 in Johannesburg. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 17, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Johannesburg (South Africa)
Additional Details
Clinical Investigator (CI)